首页/数据集/Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer

Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer

ChEBI2015-06-30 更新2026-07-12 收录

PDX肿瘤模型

前列腺癌精准治疗

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-70380 数据链接链接失效反馈

官方服务：

资源简介：

Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer

应用场景：

创建时间：

2015-06-30

肿瘤抗原鉴定

PDX肿瘤模型

Personalized cancer immunotherapy targeting patient-specific cancer/testis (CTA) antigens and neoantigens may benefit from large-scale tumor HLA peptidome (immunopeptidome) analysis, which aims to acc

NIAID Data Ecosystem60

Data_Sheet_1_Problems and Promises of Introducing the Magnetic Resonance Imaging Linear Accelerator Into Routine Care: The Case of Prostate Cancer.docx

肿瘤放射治疗

前列腺癌精准治疗

The new radiotherapy high field, 1.5 Tesla MRI-guided linear accelerator (MR-Linac) is being clinically introduced. Sensing and evaluating opportunities and barriers at an early stage will facilitate

NIAID Data Ecosystem40

Molecular determinants of response to high dose androgen therapy in prostate cancer

前列腺癌精准治疗

激素生物标志物

Clinical trials of high-dose androgen therapy for prostate cancer have shown promising efficacy but are limited by lack of criteria to identify likely responders. To elucidate factors that govern the

NIAID Data Ecosystem30

Genotyping frequencies and the association of genotype with disease progression during ADT.

前列腺癌精准治疗

基因型-表型关联分析

Abbreviations: ADT, androgen-deprivation therapy; HR, hazard ratio; 95% CI, 95% confidence interval; PSA, prostate-specific antigen. *P values were calculated using the log-rank test. †HRs were adjust

NIAID Data Ecosystem40

Evaluating the Clinical Impact of a Genomic Classifier in Prostate Cancer Using Individualized Decision Analysis

前列腺癌精准治疗

基因组临床决策

Background Currently there is controversy surrounding the optimal way to treat patients with prostate cancer in the post-prostatectomy setting. Adjuvant therapies carry possible benefits of improved c

NIAID Data Ecosystem30

Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer

资源简介：

相关数据集